ACADIA Pharmaceuticals, Inc. (NASDAQ:ACAD)

CAPS Rating: 2 out of 5

The Company is a biopharmaceutical company focused on the discovery, development, and commercialization of small molecule drugs for the treatment of central nervous system disorders.

Recs

0
Player Avatar FesterFumble (51.19) Submitted: 2/28/2013 3:46:34 AM : Outperform Start Price: $6.05 ACAD Score: +6.85

Looks cheap.

Featured Broker Partners


Advertisement